Can a website curb overprescribing of addictive anxiety pills?
NCT ID NCT07379073
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving doctors access to a special website can help them follow guidelines for prescribing benzodiazepines (medicines for anxiety and sleep). About 100 general practitioners in France will either get the website or continue as usual. Researchers will check prescription records to see if the website leads to shorter, safer treatment durations.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Training intervention with access to a clinical support website (PsychoMG)
- What this could lead to
- If successful, this could give doctors a simple online tool to reduce risky long-term benzodiazepine use.
- What could go wrong
- This is a small, early-stage study in one French region. The website may not change prescribing habits, or results may not apply elsewhere.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Being a general practitioner or a specialist in general medicine. * Practicing in the Occitanie region. * Working in private practice. * Being registered under Sector 1 fee agreements. * Providing informed consent to participate in the study. * Having computer equipment in the medical office, available during consultation (desktop, laptop, tablet, or smartphone) with internet access. Exclusion criteria: \- Physicians who have been practicing for less than two years, as they are unlikely to have sufficient retrospective data on prescription reimbursements for their patients.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benzodiazepine use are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.